Band 43
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
Aus der Reihe
Progress in Drug Research
-
- Hardcover
- Taschenbuch ausgewählt
-
Sprache:Englisch
-
Auflage:Softcover reprint of the original 1st ed. 1994
- Reprint of the original 1st ed. 1969 Fr. 72.90
- Softcover reprint of the original 1st ed. 1990 Fr. 72.90
- 1. Auflage Fr. 72.90
- 1. Auflage Fr. 72.90
- 1. Auflage Fr. 137.00
- Softcover reprint of the original 1st ed. 1995 Fr. 72.90
- Softcover reprint of the original 1st ed. 1983 Fr. 72.90
- Softcover reprint of the original 1st ed. 1994 Fr. 72.90 ausgewählt
- Softcover reprint of the original 1st ed. 1993 Fr. 72.90
- Softcover reprint of the original 1st ed. 1992 Fr. 72.90
- Softcover reprint of the original 1st ed. 1987 Fr. 72.90
- Softcover reprint of the original 1st ed. 1986 Fr. 72.90
- Softcover reprint of the original 1st ed. 1997 Fr. 72.90
- Softcover reprint of the original 1st ed. 1963 Fr. 72.90
- Softcover reprint of the original 1st ed. 1996 Fr. 72.90
- Softcover reprint of the original 1st ed. 1996 Fr. 72.90
- Softcover reprint of the original 1st ed. 1979 Fr. 72.90
Fr. 72.90
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
05.02.2012
Verlag
Springer BaselSeitenzahl
334
Maße (L/B/H)
24.4/17/1.9 cm
Gewicht
581 g
Auflage
Softcover reprint of the original 1st ed. 1994
Sprache
Englisch
ISBN
978-3-0348-7158-7
Volume 43 of «Progress in Drug Research» contains five reviews and the various indexes which facilitate its use and establish the connection with the previous volumes. The articles in this volume deal with high cholesterol blood levels and other dyslipidemias; search of ideal antihypertensive drugs; the natural PQlyamines and the immune system; biologically active quinazolones and with production and action of interferons. In the 35 years the PDR has existed, the Editor has enjoyed the valuable help and advice of many colleagues. Readers, the authors of the reviews, and last but not least, the reviewers have all contributed greatly to the success of this series. Although the comments received so far have generally been favorable, it is nevertheless necessary to analyze and to reassess the current position and the future direction of such a review series. So far, it has been the Editors intention to help disseminate information on the vast domain of drug research, and to provide the reader with a tool with which to keep abreast of the latest developments and trends. The reviews in PDR are useful to the non-specialist, who can obtain an overview of a particular field of drug research in a relatively short time. The specialist readers of PDR will appreciate the reviews' comprehensive bibliographies, and, in addition, they may even get fresh impulses for their own research. Finally, the readers can use the 43 volumes of PDR as an encyclopedic source of information.
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.